1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report

Les Laboratoires Servier: Company & Financial Report

  • August 2018
  • 46 pages
  • ID: 4585653
In this report:
Year 2014 : Contracts/Agreements; In 2014, Servier, the CNRS, and the Universities of Montpellier ## and ## signed a research collaboration contract to develop a treatment that would reduce the size of myocardial infarction, thus limiting cardiac cell death by apoptosis during the phase of myocardial reperfusion.
Year 2011 : Contracts/Agreements; In 2011, Servier and Miragen signed a $##-million partnership agreement for the research, development and commercialization of microRNA-targeting drugs for cardiovascular disease.

Summary

Table of Contents

Search Inside

Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report

Brief

Les Laboratoires Servier - This report is an all-inclusive source of corporate data and information. The study describes the company's organization, performance, strengths, weaknesses, opportunities and threats analysis, as well as products and services, and corporate activities, offering a 360? overview of the company.

Key Findings

Les Laboratoires Servier is an independent French-based pharmaceutical company. The company manufactures medicines and generic drugs. It also provides therapeutic solutions to address unmet medical needs in the areas of cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, oncology and diabetes. The company manufactures generics through its independent subsidiaries including Biogaran, Egis, and Pharlab. The company through its French subsidiary distributes medicines in France (FR), Brazil (BR) and Nigeria and through Hungarian subsidiary markets its products in Hungary, Russian Federation, Eastern Europe and Central Europe. Servier affords eHealth solutions to oversee the entire course of patient care, from prevention to follow-up. It has operations across the globe. Servier is based in Suresnes, France (FR).

Overview

- Comprehensive data on Les Laboratoires Servier needed to understand the competitive landscape and business

- A study of the main internal and external factors affecting Les Laboratoires Servier with the study of the strengths, weaknesses, opportunities and threats

- A detailed panorama of the business model of Les Laboratoires Servier such as a classification and an overview of the main segments of the business

- Insights on Les Laboratoires Servier's M&A, important business deals, legal and financial advisors, capital raising and investment funds

- News about Les Laboratoires Servier, including industry restructuring, expansion and agreements closed

- Large number of easy-to-grip charts and graphs that exhibit crucial information and key forecasts

Purposes to acquire this study

- Gain understanding of Les Laboratoires Servier and the elements impacting the strategy of the company.

- Track tactical initiatives of the company and recent business news and actions.

- Assess Les Laboratoires Servier as a potential competitor or partner.

- Support sales activities by understanding your clients' businesses better.

- Stay up to date on Les Laboratoires Servier's corporate and business organization, action plans and perspectives.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • July 2018
  • by Global Markets Direct

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out ...

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • July 2018
  • by Global Markets Direct

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018SummaryInterleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen ...

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H2 2018

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • July 2018
  • by Global Markets Direct

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog ...


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on